U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT03394612) titled 'Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children' on Dec. 7, 2017.
Brief Summary: This phase II trial aims to evaluate the efficacy and safety of EHSG-KF (synonym denovoSkin) in comparison to meshed STSG in adults and children with full-thickness Skin defects.
Study Type: Interventional
Condition: Skin Wound
Intervention: * Biological: EHSG-KF
Transplantation of autologous dermo-epidermal skin substitute EHSG-KF to the experimental area
Other Name: denovoSkin
* Biological: STSG
Transplantation of autologous split-thickness skin graft to the contro...